Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy
- PMID: 20686276
- DOI: 10.2169/internalmedicine.49.3615
Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy
Abstract
Background: Non-erosive reflux disease (NERD) is a more difficult to treat than reflux esophagitis (RE) due to the high prevalence of PPI resistance. Consequently, the treatment strategy for NERD is yet to be established.
Patients and methods: Subjects were 467 GERD patients (NERD 349, RE 118, 47.4 +/- 16.7 years) with reflux symptoms such as heartburn. PPI was administered for 2 weeks, and total score (TS) of symptoms, seven items of reflux symptoms e.g. heartburn (reflux score: RS), and five items of dyspeptic symptoms e.g. heavy stomach (dyspeptic score: DS) were assessed using the frequency scale for the symptoms of GERD (FSSG), a GERD-specific questionnaire developed in Japan. Improvement <50% in TS was defined as non-responder. Patients' background, and pretreatment TS, RS, DS, and 12 items of FSSG were assessed. Furthermore, the effect of additional prokinetics (4 weeks) for 117 PPI non-response NERD patients was also examined.
Results: Younger age, constipation, higher TS, DS, F2 (bloated stomach), 3 (heavy stomach), 5 (sick feeling after meal), 8 (satiety during meal) in FSSG were factors to be PPI non-responders in NERD. Significant improvement in TS were observed (pretreatment: 17.4 +/- 7.7 vs. 2 weeks 14.6 +/- 6.0 vs. 6 weeks 7.7 +/- 5.2, p<0.0001) after the addition of prokinetics in PPI non-response NERD.
Conclusion: Younger age, constipation, dysmotility were factors of PPI non-response in NERD. As high DS is correlated with PPI non-response, it is indicated that patients with strong dysmotility and functional dyspepsia complication might be PPI resistant. The efficacy of additional prokinetics for PPI non-response NERD was observed.
Similar articles
-
Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan.J Gastroenterol. 2011 Nov;46(11):1273-83. doi: 10.1007/s00535-011-0446-2. Epub 2011 Aug 24. J Gastroenterol. 2011. PMID: 21861141 Clinical Trial.
-
Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease.Aliment Pharmacol Ther. 2018 Nov;48(10):1074-1081. doi: 10.1111/apt.14986. Epub 2018 Oct 7. Aliment Pharmacol Ther. 2018. PMID: 30294924
-
Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease.J Dig Dis. 2014 Sep;15(9):469-76. doi: 10.1111/1751-2980.12167. J Dig Dis. 2014. PMID: 24957863 Clinical Trial.
-
Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta-analysis.World J Gastroenterol. 2014 Mar 7;20(9):2412-9. doi: 10.3748/wjg.v20.i9.2412. World J Gastroenterol. 2014. PMID: 24605040 Free PMC article. Review.
-
A systematic review and meta-analysis of the efficacy of vonoprazan for proton pump inhibitor-resistant gastroesophageal reflux disease.J Gastroenterol Hepatol. 2024 May;39(5):796-805. doi: 10.1111/jgh.16475. Epub 2024 Jan 23. J Gastroenterol Hepatol. 2024. PMID: 38263507
Cited by
-
Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study.J Gastroenterol. 2015 Dec;50(12):1173-83. doi: 10.1007/s00535-015-1073-0. Epub 2015 Apr 8. J Gastroenterol. 2015. PMID: 25851931
-
Management of refractory typical GERD symptoms.Nat Rev Gastroenterol Hepatol. 2016 May;13(5):281-94. doi: 10.1038/nrgastro.2016.50. Epub 2016 Apr 14. Nat Rev Gastroenterol Hepatol. 2016. PMID: 27075264 Review.
-
Gastroesophageal Reflux Disease: Pathophysiology and New Treatment Trends.Intern Med. 2024 Jan 1;63(1):1-10. doi: 10.2169/internalmedicine.1551-23. Epub 2023 Mar 15. Intern Med. 2024. PMID: 36927966 Free PMC article.
-
Management of the patient with incomplete response to PPI therapy.Best Pract Res Clin Gastroenterol. 2013 Jun;27(3):401-14. doi: 10.1016/j.bpg.2013.06.005. Best Pract Res Clin Gastroenterol. 2013. PMID: 23998978 Free PMC article. Review.
-
Effect of proton pump inhibition on acid, weakly acid and weakly alkaline gastro-esophageal reflux in children.World J Pediatr. 2013 Feb;9(1):36-41. doi: 10.1007/s12519-013-0405-5. Epub 2013 Feb 7. World J Pediatr. 2013. PMID: 23389331
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous